Robert Dempsey is the founder of AsclepiX Therapeutics. Latest round: Series A. Backed by Perceptive Advisors, Hibiscus Capital Management Fund II.
Robert Dempsey is the Chief Executive Officer and President of AsclepiX Therapeutics, Inc., a role he has held since March 2021. He leads the company's clinical development program for AXT107 and announced the closing of a $10 million Series A-3 financing round in 2023. Dempsey also serves as Chair of the Board of Directors at TearSolutions Inc. since December 2023.
Full founder directory · Investor directory · Company funding database · Fundraising library